Cantor Fitzgerald reissued their hold rating on shares of Envision Healthcare Corporation (NYSE:EVHC) in a research note released on Tuesday morning. Cantor Fitzgerald currently has a $30.00 price target on the stock.
“Early today, Bloomberg reported that EVHC has attracted buyout interest from private equity firms, including Carlyle Group and Onex Corp., which may bid for EVHC alone or as part of a group. Shares rose as much as 14% during the day and closed up 10.3%.”,” Cantor Fitzgerald’s analyst commented.
EVHC has been the topic of a number of other reports. Bank of America Corporation dropped their price objective on Envision Healthcare Corporation from $72.00 to $60.00 and set a buy rating on the stock in a research note on Monday, October 9th. Citigroup Inc. downgraded Envision Healthcare Corporation from a buy rating to a neutral rating and set a $31.00 price objective on the stock. in a research note on Thursday, November 2nd. Mizuho set a $57.00 price objective on Envision Healthcare Corporation and gave the company a hold rating in a research note on Tuesday, October 31st. SunTrust Banks, Inc. set a $55.00 price target on Envision Healthcare Corporation and gave the stock a buy rating in a research note on Sunday, October 15th. Finally, KeyCorp dropped their price target on Envision Healthcare Corporation from $67.00 to $37.00 and set an overweight rating on the stock in a research note on Thursday, November 2nd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus price target of $47.57.
Shares of Envision Healthcare Corporation (NYSE:EVHC) traded down $0.20 on Tuesday, hitting $29.05. The stock had a trading volume of 3,547,183 shares, compared to its average volume of 2,188,893. Envision Healthcare Corporation has a one year low of $23.77 and a one year high of $74.75. The company has a market cap of $3,440.00, a price-to-earnings ratio of 8.80, a price-to-earnings-growth ratio of 0.74 and a beta of 0.69. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01.
Envision Healthcare Corporation (NYSE:EVHC) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm’s revenue for the quarter was up 142.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.13 earnings per share. equities analysts expect that Envision Healthcare Corporation will post 2.56 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This article was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://stocknewstimes.com/2017/11/17/envision-healthcare-corporation-evhc-earns-hold-rating-from-cantor-fitzgerald.html.
Envision Healthcare Corporation declared that its board has initiated a stock repurchase plan on Monday, September 18th that allows the company to repurchase $250.00 million in shares. This repurchase authorization allows the company to repurchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.
Several hedge funds have recently added to or reduced their stakes in EVHC. Commonwealth Bank of Australia grew its holdings in shares of Envision Healthcare Corporation by 24.3% in the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock valued at $130,000 after acquiring an additional 410 shares in the last quarter. LMR Partners LLP bought a new position in shares of Envision Healthcare Corporation in the second quarter valued at approximately $205,000. Palisade Capital Management LLC NJ bought a new position in shares of Envision Healthcare Corporation in the third quarter valued at approximately $229,000. Cutter & CO Brokerage Inc. grew its holdings in shares of Envision Healthcare Corporation by 11.1% in the second quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock valued at $230,000 after acquiring an additional 367 shares in the last quarter. Finally, HighTower Advisors LLC grew its holdings in shares of Envision Healthcare Corporation by 5.6% in the first quarter. HighTower Advisors LLC now owns 4,541 shares of the company’s stock valued at $274,000 after acquiring an additional 240 shares in the last quarter.
Envision Healthcare Corporation Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.